What does IBEKLEVIC do?

IBEKLEVIC is a specialist medical practice in Pont-à-Celles. Private Limited, started on 27 February 2019, 1 establishment.

What is the address of IBEKLEVIC?

The registered office of IBEKLEVIC is located at Rue des Petits Sarts(VIE) 17, 6230 Pont-à-Celles.

Is IBEKLEVIC still active?

Yes. According to the CBE (30 October 2026) IBEKLEVIC is active, legal situation “Normale toestand”, started on 27 February 2019.

Is IBEKLEVIC registered on Peppol?

Yes, IBEKLEVIC is registered on the Peppol network with ID 0208:0721624174.

What is the enterprise number of IBEKLEVIC?

The enterprise number of IBEKLEVIC is BE0721624174.

When was IBEKLEVIC founded?

IBEKLEVIC was founded on 27 February 2019.

Is IBEKLEVIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2019; 5 annual accounts filed, latest fiscal year 2025.

How much profit did IBEKLEVIC make in 2025?

IBEKLEVIC posted a profit after taxes of € 236,181 in financial year 2025.

What is the revenue of IBEKLEVIC?

As a small company, IBEKLEVIC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 380,887.

IBEKLEVIC (Private Limited) - Pont-à-Celles

Dossier IBEKLEVIC, printed on 30 October 2026 from databakkes.be/en/0721624174/ibeklevic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

IBEKLEVIC from Pont-à-Celles, company number BE0721624174, closed financial year 2025 with a result of € 236,181 after tax. For that financial year IBEKLEVIC recorded a gross margin of € 380,887 and equity of € 621,831. Compared with financial year 2024, the result moved from € 194,199 to € 236,181. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2026.

What it is worth Growing

€ 621,831

▲ 61% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 236,181

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 179,935

▼ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 609,431.

People and assets in 2025

Wage cost

€ 22,076

▼ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,615

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,221

▼ 28% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 91,403 Gross margin 2022: € 91,403 First fiscal year in the series	€ 281,222 Gross margin 2023: € 281,222 ▲ 208% vs 2022 (€ 91,403) Favourable step	€ 322,625 Gross margin 2024: € 322,625 ▲ 15% vs 2023 (€ 281,222) Favourable step	€ 380,887 Gross margin 2025: € 380,887 ▲ 18% vs 2024 (€ 322,625) Favourable step	▲ 18%
Profit after taxes	€ 57,712 Profit after taxes 2022: € 57,712 First fiscal year in the series	€ 200,180 Profit after taxes 2023: € 200,180 ▲ 247% vs 2022 (€ 57,712) Favourable step	€ 194,199 Profit after taxes 2024: € 194,199 ▼ 3% vs 2023 (€ 200,180) Unfavourable step	€ 236,181 Profit after taxes 2025: € 236,181 ▲ 22% vs 2024 (€ 194,199) Favourable step	▲ 22%
Equity	€ 256,272 Equity 2022: € 256,272 First fiscal year in the series	€ 246,452 Equity 2023: € 246,452 ▼ 4% vs 2022 (€ 256,272) Unfavourable step	€ 385,651 Equity 2024: € 385,651 ▲ 56% vs 2023 (€ 246,452) Favourable step	€ 621,831 Equity 2025: € 621,831 ▲ 61% vs 2024 (€ 385,651) Favourable step	▲ 61%
Total debts	€ 32,340 Total debts 2022: € 32,340 First fiscal year in the series	€ 143,608 Total debts 2023: € 143,608 ▲ € 111,268 vs 2022 (€ 32,340) Unfavourable step	€ 106,013 Total debts 2024: € 106,013 ▼ 26% vs 2023 (€ 143,608) Favourable step	€ 37,336 Total debts 2025: € 37,336 ▼ 65% vs 2024 (€ 106,013) Favourable step	▼ 65%
Cash	€ 227,634 Cash 2022: € 227,634 First fiscal year in the series	€ 232,315 Cash 2023: € 232,315 ▲ 2% vs 2022 (€ 227,634) Favourable step	€ 345,058 Cash 2024: € 345,058 ▲ 49% vs 2023 (€ 232,315) Favourable step	€ 179,935 Cash 2025: € 179,935 ▼ 48% vs 2024 (€ 345,058) Unfavourable step	▼ 48%
Retained profit	€ 243,872 Retained profit 2022: € 243,872 First fiscal year in the series	€ 234,052 Retained profit 2023: € 234,052 ▼ 4% vs 2022 (€ 243,872) Unfavourable step	€ 373,251 Retained profit 2024: € 373,251 ▲ 59% vs 2023 (€ 234,052) Favourable step	€ 609,431 Retained profit 2025: € 609,431 ▲ 63% vs 2024 (€ 373,251) Favourable step	▲ 63%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 210,000 Dividend 2023: € 210,000 Unchanged (€ 0) Unchanged	€ 55,000 Dividend 2024: € 55,000 ▼ 74% vs 2023 (€ 210,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 55,000) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 1,000 Bank debt 2024: € 1,000 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 1,000) Favourable step	▼ 100%
Balance sheet total	€ 288,612 Balance sheet total 2022: € 288,612 First fiscal year in the series	€ 390,060 Balance sheet total 2023: € 390,060 ▲ 35% vs 2022 (€ 288,612) Unchanged	€ 491,664 Balance sheet total 2024: € 491,664 ▲ 26% vs 2023 (€ 390,060) Unchanged	€ 659,167 Balance sheet total 2025: € 659,167 ▲ 34% vs 2024 (€ 491,664) Unchanged	▲ 34%
Employees (FTE)	-	0.1 Employees (FTE) 2023: 0.1 First fiscal year in the series	-	-

Key figures of IBEKLEVIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IBEKLEVIC?

What happened at IBEKLEVIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 4, 2026 New annual accounts for financial year 2025: profit of € 236,181 (▲ 22% vs 2024). Source: NBB ↗
Feb 28, 2019 New establishment in Charleroi. KBO
Feb 27, 2019 Start of the company according to the CBE. KBO

In short

From € 57,712 profit in 2022 to € 236,181 profit in 2025.

Paid € 303,943 in corporate taxes since 2022.

Best year ever: 2025, with € 236,181 profit.

Paid out € 265,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Petits Sarts(VIE) 17

6230 Pont-à-Celles

2.287.666.806

Rue de l'Escasse 18 box 12

6041 Charleroi

Active since 28 February 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0721.624.174
VAT number: BE 0721.624.174
Registered office: Rue des Petits Sarts(VIE) 17, 6230 Pont-à-Celles
Names & denominations: IBEKLEVIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 February 2019
Peppol: Active · Active since 6 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

IBEKLEVIC